210 related articles for article (PubMed ID: 38036980)
41. Surfactant and respiratory distress syndrome.
Milner AD
Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
[TBL] [Abstract][Full Text] [Related]
42. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll R; Wiswell TE
Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
[TBL] [Abstract][Full Text] [Related]
43. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
Ardell S; Pfister RH; Soll R
Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
[TBL] [Abstract][Full Text] [Related]
44. [Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].
Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants
Zhonghua Er Ke Za Zhi; 2021 Apr; 59(4):273-279. PubMed ID: 33775045
[No Abstract] [Full Text] [Related]
45. Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome.
Izadi R; Shojaei P; Haqbin A; Habibolahi A; Sadeghi-Moghaddam P
PLoS One; 2023; 18(6):e0286997. PubMed ID: 37390082
[TBL] [Abstract][Full Text] [Related]
46. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of Initial Respiratory Support Strategies in VLBW Neonates with RDS.
Afjeh SA; Sabzehei MK; Khoshnood Shariati M; Shamshiri AR; Esmaili F
Arch Iran Med; 2017 Mar; 20(3):158-164. PubMed ID: 28287810
[TBL] [Abstract][Full Text] [Related]
48. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
Fujii A; Allen R; Doros G; O'Brien S
J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
[TBL] [Abstract][Full Text] [Related]
49. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study.
Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z
Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103
[TBL] [Abstract][Full Text] [Related]
50. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial.
Kandraju H; Murki S; Subramanian S; Gaddam P; Deorari A; Kumar P
Neonatology; 2013; 103(2):148-54. PubMed ID: 23235135
[TBL] [Abstract][Full Text] [Related]
51. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
[TBL] [Abstract][Full Text] [Related]
52. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
[TBL] [Abstract][Full Text] [Related]
53. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS
Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
[TBL] [Abstract][Full Text] [Related]
54. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll R; Ozek E
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513
[TBL] [Abstract][Full Text] [Related]
55. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
Gortner L
J Perinat Med; 1992; 20(6):409-19. PubMed ID: 1293266
[TBL] [Abstract][Full Text] [Related]
56. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
[TBL] [Abstract][Full Text] [Related]
57. Continuous positive airway pressure for spontaneously breathing premature infants with respiratory distress syndrome.
Saxena A; Thapar RK; Sondhi V; Chandra P
Indian J Pediatr; 2012 Sep; 79(9):1185-91. PubMed ID: 22396227
[TBL] [Abstract][Full Text] [Related]
58. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
59. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
60. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
